To obtain the perspective of individuals with systemic lupus erythematosus (SLE) regarding the role of poverty, neighborhood, and chronic stress in SLE outcomes. To read the full article, log in using your NHS OpenAthens details.
Rheumatoid arthritis is an autoimmune disease that causes joint inflammation. It affects around 400,000 people in the UK and 1 million adults in the USA. Given the appropriate treatment, many can have relatively few symptoms. It is therefore important to understand what it is like to live with rheumatoid arthritis and gain insight into peoples’ decisions about utilising healthcare. The aims of this study were: (1) to bring together qualitative evidence syntheses that explore patients’ experience of living with rheumatoid arthritis and (2) develop a conceptual understanding of what it is like to live with rheumatoid arthritis. Open Access
Cervical spine involvement in patients with rheumatoid arthritis (RA) can cause pain and disability, with a variety of neurologic signs and symptoms. To read the full article, log in using your MPFT NHS OpenAthens details.
Frequent monitoring of early rheumatoid arthritis (RA) patients is required for achieving good outcomes. We studied the influence of text message (SMS) enhanced monitoring on early RA outcomes. To read the full article, log in using your NHS OpenAthens details.
Aim: To summarise the effectiveness of organisational interventions on appropriate opioid prescribing for non-cancer pain upon hospital discharge. To read the full article, choose Open Athens “Institutional Login” and search for “Midlands Partnership”.
Rheumatoid arthritis (RA) and osteoarthritis (OA) both are chronic diseases affecting joints. There is a hypothesis that suppression of immune response vs collagen could be a therapeutic approach in RA and OA. To read the full article, choose Open Athens “Institutional Login” and search for “Midlands Partnership”.
Systemic lupus erythematosus (SLE) with severe coronary artery disease (CAD) is associated with increased mortality. This study aimed to assess the characteristics and risk factors of severe CAD in SLE. To read the full article, choose Open Athens “Institutional Login” and search for “Midlands Partnership”.
The objective of this systematic review was to evaluate the efficacy of immunosuppressive therapy in patients with connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) and to further assess whether response differs between CTD subtypes and clinical features. To read the full article, choose “Institutional Login” and search for “Midlands Partnership”.
Rheumatoid arthritis (RA) is a systemic autoimmune polyarticular disease. Despite being commonly affected in RA, the ankle and foot do not receive much attention, particularly in early disease. The precise diagnosis of their involvement and its impact on health is a clinical challenge that requires accurate assessment. To read the full article, choose Open Athens “Institutional Login” and search for “Midlands Partnership”.
Secukinumab, the first IL-17A inhibitor, is widely used to treat immune diseases, including plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis. Here, we aimed to explore the clinical characteristics, outcomes, and time to onset of the four main toxicities of secukinumab, using post-marketing data. To read the full article, choose Open Athens “Institutional Login” and search for “Midlands Partnership”.
Since 2010, biological disease-modifying antirheumatic drugs (bDMARDs) have been the dominant mode of treatment for rheumatoid arthritis (RA). However, the safety of DMARDs, such as tumor necrosis factor inhibitors (TNFis) and Janus kinase inhibitors (JAKis), in treating patients with RA is a concern. We compared the safety outcomes of JAKis and TNFis in RA patients in clinical settings. To read the full article, choose Open Athens “Institutional Login” and search for “Midlands Partnership”.
This work aims to evaluate the peripheral nerves and muscle involvement after COVID-19 infection, in addition to studying the prevalence rate and risk factors of their affection. To read the full article, choose Open Athens “Institutional Login” and search for “Midlands Partnership”.
Schools play a key role in adolescents' experiences with managing ME/CFS. However, little is known about the experiences of adolescents with ME/CFS (and their families) in schools. This paper is an incidental qualitative study, which combines data from two independent ME/CFS studies: study 1 researched ethnic minority adolescents with ME/CFS; study 2 explored Acceptance and Commitment Therapy for adolescents with ME/CFS who had not recovered after one year. To read the full article, choose Open Athens “Institutional Login” and search for “Midlands Partnership”.
Systemic lupus erythematosus (SLE) is a heterogeneous systemic autoimmune diseases (AIDs) with many pathogenic factors, ranging from genetic to epigenetic to environmental. In this article, we provide a report of a case of SLE onset following HPV vaccination and a review of 11 similar cases. To read the full article, choose Open Athens “Institutional Login” and search for “Midlands Partnership”.
The study demonstrates the potential of integrating traditional biomarkers with unsupervised clustering algorithms in understanding the heterogeneity of AoSD. To read the full article, choose Open Athens “Institutional Login” and search for “Midlands Partnership”.
The current study aims to assess the efficacy of baricitinib in treating SLE patients. To read the full article, choose Open Athens “Institutional Login” and search for “Midlands Partnership”.
This study aims to evaluate the long-term efficacy, safety, and cumulative retention rate of antitumor necrosis factor-alpha (anti-TNF-α) therapy for patients with Behcet's uveitis (BU) using meta-analysis. To read the full article, choose Open Athens “Institutional Login” and search for “Midlands Partnership”.
This guideline updates recommendations for prevention and treatment of glucocorticoid-induced osteoporosis (GIOP) for patients with rheumatic or nonrheumatic conditions receiving >3 months treatment with glucocorticoids (GCs) ≥2.5 mg daily. To read the full article, choose Open Athens “Institutional Login” and search for “Midlands Partnership”.
This population-based study investigated the incidence and factors associated with mental illness among patients with rheumatoid arthritis receiving b/tsDMARDs. To read the full article, choose Open Athens “Institutional Login” and search for “Midlands Partnership”.